Cargando…
BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL
SIMPLE SUMMARY: T-cell lymphoma is a cancer of the immune system. One specific sub-type of T-cell lymphoma is a malignancy called anaplastic large cell lymphoma (ALCL), which is distinct from the other forms, as in general, it has a better prognosis. Research conducted to understand why ALCL develop...
Autores principales: | Garland, Gavin D., Ducray, Stephen P., Jahangiri, Leila, Pucci, Perla, Amos Burke, G. A., Monahan, Jack, Lai, Raymond, Merkel, Olaf, Schiefer, Ana-Iris, Kenner, Lukas, Bannister, Andrew J., Turner, Suzanne D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750310/ https://www.ncbi.nlm.nih.gov/pubmed/35008316 http://dx.doi.org/10.3390/cancers14010151 |
Ejemplares similares
-
The BRG1 transcriptional coregulator
por: Trotter, Kevin W., et al.
Publicado: (2008) -
BRG1: Promoter or Suppressor of Cancer? The Outcome of BRG1’s Interaction with Specific Cellular Pathways
por: Shaykevich, Aaron, et al.
Publicado: (2023) -
On the Interaction Between SMARCAL1 and BRG1
por: Bisht, Deepa, et al.
Publicado: (2022) -
Mechanism of BRG1 silencing in primary cancers
por: Marquez, Stefanie B., et al.
Publicado: (2016) -
The Role of BRG1 in Antioxidant and Redox Signaling
por: You, Shilong, et al.
Publicado: (2020)